Table of Contents Author Guidelines Submit a Manuscript
Letter to the Editor
Journal of Thyroid Research
Volume 2014, Article ID 218763, 9 pages
http://dx.doi.org/10.1155/2014/218763
Research Article

The Beneficial Effects of Valproic Acid in Thyroid Cancer Are Mediated through Promoting Redifferentiation and Reducing Stemness Level: An In Vitro Study

1Endocrinology and Metabolism Research Center, Endocrinology and Metabolism Clinical Sciences Institute, Tehran University of Medical Sciences, P.O. Box 1411413137, Tehran, Iran
2Institute of Biochemistry and Biophysics (IBB), University of Tehran, P.O. Box 13145-1384, Tehran, Iran
3Hematology, Oncology, and Bone Marrow Transplantation Research Center, Tehran University of Medical Sciences, P.O. Box 1411413137, Tehran, Iran

Received 22 September 2013; Revised 11 April 2014; Accepted 28 April 2014; Published 15 May 2014

Academic Editor: Thomas J. Fahey

Copyright © 2014 Vahid Haghpanah et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. C. Schmutzler and J. Koehrle, “Innovative strategies for the treatment of thyroid cancer,” The European Journal of Endocrinology, vol. 143, no. 1, pp. 15–24, 2000. View at Google Scholar · View at Scopus
  2. A. Vivaldi, F. Y. Miasaki, R. Ciampi et al., “Re-differentiation of thyroid carcinoma cell lines treated with 5-Aza-2′-deoxycytidine and retinoic acid,” Molecular and Cellular Endocrinology, vol. 307, no. 1-2, pp. 142–148, 2009. View at Publisher · View at Google Scholar · View at Scopus
  3. D. Shibru, K. W. Chung, and E. Kebebew, “Recent developments in the clinical application of thyroid cancer biomarkers,” Current Opinion in Oncology, vol. 20, no. 1, pp. 13–18, 2008. View at Publisher · View at Google Scholar · View at Scopus
  4. T. Takano and N. Amino, “Fetal cell carcinogenesis: a new hypothesis for better understanding of thyroid carcinoma,” Thyroid, vol. 15, no. 5, pp. 432–438, 2005. View at Publisher · View at Google Scholar · View at Scopus
  5. G. Zito, P. Richiusa, A. Bommarito et al., “In vitro identification and characterization of CD133(pos) cancer stem-like cells in anaplastic thyroid carcinoma cell lines,” PLoS ONE, vol. 3, no. 10, Article ID e3544, 2008. View at Publisher · View at Google Scholar · View at Scopus
  6. M. Derwahl, “Linking stem cells to thyroid cancer,” Journal of Clinical Endocrinology and Metabolism, vol. 96, no. 3, pp. 610–613, 2011. View at Publisher · View at Google Scholar · View at Scopus
  7. N. Mitsutake, A. Iwao, K. Nagai et al., “Characterization of side population in thyroid cancer cell lines: cancer stem-like cells are enriched partly but not exclusively,” Endocrinology, vol. 148, no. 4, pp. 1797–1803, 2007. View at Publisher · View at Google Scholar · View at Scopus
  8. S. Sell, “Cancer stem cells and differentiation therapy,” Tumor Biology, vol. 27, no. 2, pp. 59–70, 2006. View at Publisher · View at Google Scholar · View at Scopus
  9. J. E. Bolden, M. J. Peart, and R. W. Johnstone, “Anticancer activities of histone deacetylase inhibitors,” Nature Reviews Drug Discovery, vol. 5, no. 9, pp. 769–784, 2006. View at Publisher · View at Google Scholar · View at Scopus
  10. S. Lee, J. R. Park, M. S. Seo et al., “Histone deacetylase inhibitors decrease proliferation potential and multilineage differentiation capability of human mesenchymal stem cells,” Cell Proliferation, vol. 42, no. 6, pp. 711–720, 2009. View at Publisher · View at Google Scholar · View at Scopus
  11. S. R. Choudhury, S. Karmakar, N. L. Banik, and S. K. Ray, “Valproic acid induced differentiation and potentiated efficacy of taxol and nanotaxol for controlling growth of human glioblastoma LN18 and T98G Cells,” Neurochemical Research, vol. 36, no. 12, pp. 2292–2305, 2011. View at Publisher · View at Google Scholar · View at Scopus
  12. C. P. Gan, S. Hamid, S. Y. Hor et al., “Valproic acid: growth inhibition of head and neck cancer by induction of terminal differentiation and senescence,” Head and Neck, vol. 34, no. 3, pp. 344–353, 2012. View at Publisher · View at Google Scholar · View at Scopus
  13. S. Landreville, O. A. Agapova, K. A. Matatall et al., “Histone deacetylase inhibitors induce growth arrest and differentiation in uveal melanoma,” Clinical Cancer Research, vol. 18, no. 2, pp. 408–416, 2012. View at Publisher · View at Google Scholar · View at Scopus
  14. M. Malehmir, V. Haghpanah, B. Larijani et al., “Multifaceted suppression of aggressive behavior of thyroid carcinoma by all-trans retinoic acid induced re-differentiation,” Molecular and Cellular Endocrinology, vol. 348, no. 1, pp. 260–269, 2012. View at Publisher · View at Google Scholar · View at Scopus
  15. M. Todaro, F. Iovino, V. Eterno et al., “Tumorigenic and metastatic activity of human thyroid cancer stem cells,” Cancer Research, vol. 70, no. 21, pp. 8874–8885, 2010. View at Publisher · View at Google Scholar · View at Scopus
  16. S. Friedman, M. Lu, A. Schultz, D. Thomas, and R. Y. Lin, “CD133+ anaplastic thyroid cancer cells initiate tumors in immunodeficient mice and are regulated by thyrotropin,” PLoS ONE, vol. 4, no. 4, Article ID e5395, 2009. View at Publisher · View at Google Scholar · View at Scopus
  17. R. Y. Lin, “Thyroid cancer stem cells,” Nature Reviews Endocrinology, vol. 7, no. 10, pp. 609–616, 2011. View at Publisher · View at Google Scholar · View at Scopus
  18. N. Fortunati, M. G. Catalano, K. Arena, E. Brignardello, A. Piovesan, and G. Boccuzzi, “Valproic acid induces the expression of the Na+/I symporter and iodine uptake in poorly differentiated thyroid cancer cells,” Journal of Clinical Endocrinology and Metabolism, vol. 89, no. 2, pp. 1006–1009, 2004. View at Publisher · View at Google Scholar · View at Scopus
  19. S. Chateauvieux, F. Morceau, M. Dicato, and M. Diederich, “Molecular and therapeutic potential and toxicity of valproic acid,” Journal of Biomedicine and Biotechnology, vol. 2010, Article ID 479364, 18 pages, 2010. View at Publisher · View at Google Scholar · View at Scopus
  20. M. G. Catalano, N. Fortunati, M. Pugliese et al., “Valproic acid induces apoptosis and cell cycle arrest in poorly differentiated thyroid cancer cells,” Journal of Clinical Endocrinology and Metabolism, vol. 90, no. 3, pp. 1383–1389, 2005. View at Publisher · View at Google Scholar · View at Scopus
  21. A. M. Meireles, A. Preto, A. S. Rocha et al., “Molecular and genotypic characterization of human thyroid follicular cell carcinoma-derived cell lines,” Thyroid, vol. 17, no. 8, pp. 707–715, 2007. View at Publisher · View at Google Scholar · View at Scopus
  22. K. Ohnishi, I. Ota, A. Takahashi et al., “Glycerol as a chemical chaperone enhances radiation-induced apoptosis in anaplastic thyroid carcinoma cells,” Molecular Cancer, vol. 1, article 4, 2002. View at Publisher · View at Google Scholar · View at Scopus
  23. J. Brzezinski, A. Migodzinski, A. Toczek, J. Tazbir, and M. Dedecjus, “Patterns of cyclin E, retinoblastoma protein, and p21Cip1/WAF1 immunostaining in the oncogenesis of papillary thyroid carcinoma,” Clinical Cancer Research, vol. 11, no. 3, pp. 1037–1043, 2005. View at Google Scholar · View at Scopus
  24. H. Noguchi, H. Yamashita, T. Murakami et al., “Successful treatment of anaplastic thyroid carcinoma with a combination of oral valproic acid, chemotherapy, radiation and surgery,” Endocrine Journal, vol. 56, no. 2, pp. 245–249, 2009. View at Publisher · View at Google Scholar · View at Scopus
  25. J. Liu and R. E. Brown, “Immunohistochemical detection of epithelialmesenchymal transition associated with stemness phenotype in anaplastic thyroid carcinoma,” International Journal of Clinical and Experimental Pathology, vol. 3, no. 8, pp. 755–762, 2010. View at Google Scholar · View at Scopus
  26. R. Y. Lin, “New insights into thyroid stem cells,” Thyroid, vol. 17, no. 10, pp. 1019–1023, 2007. View at Publisher · View at Google Scholar · View at Scopus
  27. A. Kaimori, J. J. Potter, M. Choti, Z. Ding, E. Mezey, and A. A. Koteish, “Histone deacetylase inhibition suppresses the transforming growth factor beta1-induced epithelial-to-mesenchymal transition in hepatocytes,” Hepatology, vol. 52, no. 3, pp. 1033–1045, 2010. View at Publisher · View at Google Scholar · View at Scopus
  28. S. M. Kumar, S. Liu, H. Lu et al., “Acquired cancer stem cell phenotypes through Oct4-mediated dedifferentiation,” Oncogene, vol. 31, no. 47, pp. 4898–4911, 2012. View at Publisher · View at Google Scholar
  29. P. Phatak and A. M. Burger, “Telomerase and its potential for therapeutic intervention,” The British Journal of Pharmacology, vol. 152, no. 7, pp. 1003–1011, 2007. View at Publisher · View at Google Scholar · View at Scopus
  30. C. Puppin, F. d'Aurizio, A. V. d'Elia et al., “Effects of histone acetylation on sodium iodide symporter promoter and expression of thyroid-specific transcription factors,” Endocrinology, vol. 146, no. 9, pp. 3967–3974, 2005. View at Publisher · View at Google Scholar · View at Scopus
  31. E. Fröhlich, P. Brossart, and R. Wahl, “Induction of iodide uptake in transformed thyrocytes: a compound screening in cell lines,” The European Journal of Nuclear Medicine and Molecular Imaging, vol. 36, no. 5, pp. 780–790, 2009. View at Publisher · View at Google Scholar · View at Scopus
  32. L. Lan, D. Cui, K. Nowka, and M. Derwahl, “Stem cells derived from goiters in adults form spheres in response to intense growth stimulation and require thyrotropin for differentiation into thyrocytes,” Journal of Clinical Endocrinology and Metabolism, vol. 92, no. 9, pp. 3681–3688, 2007. View at Publisher · View at Google Scholar · View at Scopus
  33. I. Stamenkovic, “Matrix metalloproteinases in tumor invasion and metastasis,” Seminars in Cancer Biology, vol. 10, no. 6, pp. 415–433, 2000. View at Publisher · View at Google Scholar · View at Scopus